慢性冠脉综合征合并急性失代偿性心力衰竭患者低灌注发生的相关危险因素分析

摘要/Abstract

摘要： 目的探讨慢性冠脉综合征（CCS）合并急性失代偿性心力衰竭（ADHF）患者低灌注发生的相关性研究。方法回顾性分析本院2023年7月至2024年6月收治的120例CCS合并ADHF患者的临床资料,根据临床是否发生低灌注分为发生组60例和未发生组60例;比较两组患者临床资料、乳酸脱氢酶（LHD）、血红蛋白（Hb）、心肌肌钙蛋白I（cTnI）、N末端脑钠肽前体（NT-proBNP）、同型半胱氨酸（Hcy）、胱抑素C（CysC）水平;采用Logistic回归分析影响CCS合并ADHF患者发生低灌注的相关因素。结果发生组LHD、Hb、cTnI、NT-proBNP、Hcy及CysC水平高于对照组（P<0.05）;多因素回归分析显示,LHD、Hb、cTnI、NT-proBNP、Hcy、CysC水平升高为CCS合并ADHF患者发生低灌注的危险因素（OR=1.061、1.568、2.089、1.924、2.876、4.059）。结论 CCS合并ADHF患者LHD、Hb、cTnI、NT-proBNP、Hcy及CysC水平升高为患者发生低灌注的危险因素。

关键词: 慢性冠脉综合征, 急性失代偿性心力衰竭, 低灌注, 危险因素分析, 相关性

莫江英, 蒋琳. 慢性冠脉综合征合并急性失代偿性心力衰竭患者低灌注发生的相关危险因素分析[J]. 心血管病防治知识, 2024, 14(15): 48-51.

参考文献

[1] Gabaldon-Perez A, Marcos-Garces V, Gavara J, et al.Coronary Revascularization and Long-Term Survivorship in Chronic Coronary Syndrome[J]. J Clin Med, 2021, 10(4):610.
[2] Heidenreich PA, Bozkurt B, Aguilar D, et al.2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. Circulation, 2022, 145(18):876-e894.
[3] 杨帆, 白抚生, 尤林, 等. 依达拉奉对脑缺血再灌注损伤患者神经功能、氧化应激和炎性反应的影响[J]. 疑难病杂志, 2020, 19(9):880-883-887.
[4] 李璇, 吴江, 杨朝慧, 等. MRA、3D-ASL及IVIM技术在短暂性脑缺血发作中的应用价值研究[J]. 磁共振成像, 2020, 11(5):321-325.
[5] 李建章. 慢性脑供血不足新思维[J]. 中国实用神经疾病杂志, 2007, 10(5):1-2.
[6] Knuuti J, Wijns W, Saraste A, et al.2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes[J]. Eur Heart J, 2020, 41(3):407-477.
[7] 中国医疗保健国际交流促进会急诊医学分会, 中华医学会急诊医学分会, 中国医师协会急诊医师分会, 等. 急性心力衰竭中国急诊管理指南(2022)[J]. 中国急救医学, 2022, 42(8):648-670.
[8] Han JK, Koo BK, Park KW, et al.Optimal intravascular ultrasound criteria for defining the functional significance of intermediate coronary stenosis: an international multicenter study. Cardiology, 2014, 127(4):256-262.
[9] Virani SS, Newby LK, Arnold SV, et al.2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation, 2023, 148(9):9-119.
[10] Heidenreich PA, Bozkurt B, Aguilar D, et al.2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. Circulation, 2022, 145(18):876-894.
[11] 程春红, 李鸿波, 黄炯. MRA、3D-ASL脑灌注成像技术诊断缺血性脑血管疾病的一致性比较[J]. 中国实验诊断学, 2020, 24(5):809-811.
[12] Deng H, Gao Y, Trappetti V, et al.Targeting lactate dehydrogenase B-dependent mitochondrial metabolism affects tumor initiating cells and inhibits tumorigenesis of non-small cell lung cancer by inducing mtDNA damage[J]. Cell Mol Life Sci, 2022, 79(8):445.
[13] 王蓓丽, 李辉军, 伍严安, 等. 血清生化指标与冠心病患者冠状动脉狭窄程度的相关性[J]. 检验医学, 2020, 35(1):6-10.
[14] Hoiland RL, MacLeod DB, Stacey BS, et al. Hemoglobin and cerebral hypoxic vasodilation in humans: Evidence for nitric oxide-dependent and S-nitrosothiol mediated signal transduction[J]. J Cereb Blood Flow Metab, 2023, 43(9):1519-1531.
[15] 胡现宁, 袁涛, 刘武杰, 等. 急性缺血性卒中突出静脉征影响因素的研究现状[J].国际医学放射学杂志, 2021, 44(2):152-156.
[16] Chauin A.The Main Causes and Mechanisms of Increase in Cardiac Troponin Concentrations Other Than Acute Myocardial Infarction (Part 1): Physical Exertion, Inflammatory Heart Disease, Pulmonary Embolism, Renal Failure, Sepsis[J]. Vasc Health Risk Manag, 2021, 17:601-617.
[17] Pieske B, Wachter R, Shah SJ, et al.Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial[J]. JAMA, 2021, 326(19):1919-1929.
[18] 沈彬, 赵勇, 马军力, 等. 缺血后适应联合替罗非班干预急性ST段抬高型心肌梗死再灌注损伤的临床研究[J]. 中西医结合心脑血管病杂志, 2020, 18(9):1432-1435.
[19] Koklesova L, Mazurakova A, Samec M, et al.Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person[J]. EPMA J, 2021, 12(4):477-505.
[20] 杨阳, 贾万理, 晋婕. 血清sICAM-1、IMA、Hcy检测对AMI患者PCI术后心肌低灌注的预测价值[J]. 检验医学与临床, 2023, 20(3):303-305-309.
[21] 张卫东, 乔明刚.老年心衰并发心律失常患者血清Ang-2,Cys C水平及hs-CRP/PAB比值对临床预后评估的价值研究[J]. 现代检验医学杂志, 2021, 36(6):128-131-147.